Introduction
- Benzodiazepines are used for numerous acute states in the emergency department, especially
- IV access is often not available for patients with seizures or agitation and alternative routes must be
- This handout will focus on the pharmacokinetics of the two most utilized benzodiazepines in the
seizures and agitation
considered; the drug of choice may change depending on the route of administration
emergency department, lorazepam and midazolam
Clinical Detail
This handout focuses on the pharmacokinetics of the two most utilized benzodiazepines in the emergency department, lorazepam and midazolam, across the routes of administration most relevant when IV access is unavailable.
| Parameter | Lorazepam IV | Lorazepam IM | Midazolam IV | Midazolam IM | Midazolam IN |
|---|---|---|---|---|---|
| Dose | Sedation: 0.5–2 mg Seizure: 4 mg | Sedation: 0.5–2 mg Seizure: 0.5–2 mg (not preferred) | Sedation: 0.5–2 mg Seizure: 0.2 mg/kg (not preferred) | Sedation: 5 mg Seizure: 10 mg or 0.2 mg/kg; max 10 mg | Sedation: 0.1 mg/kg Seizure: 0.2 mg/kg; max 10 mg |
| Onset | 2–10 min (longer for anticonvulsant) | 20–30 min | 3–5 min | 15 min | 10 min |
| Duration | 3–6 hours for seizures, up to 8 hours for sedation | 6–8 hours | < 2 hours | 2–6 hours | 20–30 min |
| Bioavailability | 100% | 83–100% | 100% | 90% | 44% |
| Pros / Cons | Pro: Fastest onset | Pro: No IV access needed Con: Erratic absorption | Con: Short duration, potential for recurrence of agitation/seizure | Pro: No IV access needed | Pro: Least invasive administration Con: Small volumes (max 1 mL each nare), high-concentration drug needed |
Evidence
| Author, Year | Design / Sample Size | Intervention & Comparison | Outcome |
|---|---|---|---|
| Nobay 2004 | Prospective, double-blind, randomized N = 95 | IM midazolam vs. IM haloperidol vs. IM lorazepam for agitation | Mean time to sedation (min) Lorazepam: 32.3 (±20) Midazolam: 18.3 (±14) Haloperidol: 28.3 (±25) *Lorazepam dropped from study due to significantly longer time to sedation and awakening |
| Silbergleit 2012 | Prospective, double-blind, randomized, non-inferiority N = 893 | IM midazolam versus IV lorazepam for seizure | Seizures absent at time of arrival to ED IM midazolam: 73.4% IV lorazepam: 63.4% Statistically significant for non-inferiority |
| Haut 2016 | Systematic review N = 75 studies | Compared time to administration and time to seizure termination for multiple different benzodiazepines given by various routes | Faster time to drug administration of IM midazolam was offset by the faster onset of IV lorazepam 10 studies showed faster time to administration with IM/IN administration over IV or rectal administration, 7 of which were statistically significant |
| Owusu 2019 | Retrospective cohort N = 50 | IV lorazepam vs. IN midazolam for seizure | Median time to seizure termination IV: 0.3–5.7 min IM: 1.1–7.9 min IN: 2.3–7.5 min IV lorazepam (N = 27): 3.3 min (IQR 1.2–62.4) IN midazolam (N = 23): 3.2 min (IQR 0.1–28.5) There was no difference in the number of repeat benzodiazepine doses required or time to administration |
Conclusions
- The initial agent used does not have to be the definitive agent for treatment. Utilizing alternative
- A lack of literature directly comparing all routes of administration for all benzodiazepines should not
routes in order to obtain IV access in agitation/convulsing patients is often the safest for both the
patient and staff members. It may also allow therapy to be initiated faster than waiting to obtain
IV access.
limit utilization. Important differences exist in pharmacokinetics of each drug and route of
administration that may be beneficial for specific populations and disease states.
References
Lorazepam. Micromedex [Electronic version].Greenwood Village, CO: Truven Health Analytics. Accessed 2020, February 24.
http://www.micromedexsolutions.com/
Midazolam. Micromedex [Electronic version].Greenwood Village, CO: Truven Health Analytics. Accessed 2020, February 24.
http://www.micromedexsolutions.com/
Lorazepam. Lexicomp [online database].Hudson, OH. Woltes Kluwer Clinical Drug Information, Inc. Accessed 2020, February 24. http://www.online.lexi.com
Midazolam. Lexicomp [online database].Hudson, OH. Woltes Kluwer Clinical Drug Information, Inc. Accessed 2020, February 24. http://www.online.lexi.com
Nobay, et al. Acad Emerg Med. 2004;11(7):744-49.
Haut, et al. Epilepsy & Behavior. 2016;63:109-17.
Silbergleit, et al. NEJM. 2012;366(7):591-600.
Owusu, et al. Epilepsy & Behavior. 2019;98:161-67.
A short weekly clinical Pearl for acute care pharmacists.
Get the Friday Pearl email
Get a short weekly clinical Pearl for acute care pharmacists. No spam.
Free forever. Unsubscribe anytime. No spam.